COMPARISON AMONG BREAST CANCER’S AND BRONCHIAL-AND-LUNG CANCER’S POTENTIAL YEARS OF LIFE LOST AND UNADJUSTED MORTALITY IN WOMEN OF MIDDLE WEST BRAZIL

BRAGA, W. V. (Federal University of Goiás), SILVA, B. R. (Federal University of Goiás), DOMINGOS, J. P. F. C. (Federal University of Goiás), MENDANHA, D. M. (Federal University of Goiás), CHAGAS, P. P. (Federal University of Goiás), MACEDO, V. N. (Federal

Federal University of GoiásTo compare potential years of life lost (PYLL) rate and unadjusted proportional mortality of breast, bronchial and lung cancers in women, acknowledging the importance of its correlation and interpretation. Comparative study of unadjusted proportional mortality and PYLL per bracket age, between the years 2012 and 2014, by breast cancer (CID C50) and bronchial-and-lung cancer (CID C34) in women of Middle West Brazil. Data were obtained from On-line Mortality Atlas of National Cancer Institute of Brazil, using type of cancer topography and 80 years as superior limit, in February 15th 2017. Women of middle west Brazil are later affected by breast cancer than by bronchial-and-lung cancer according to the PYLL, giving that the superior limit is 80 years for both and the first begins in the 20-29 age bracket and the second in the 15-20 one. The unadjusted proportional mortality is bigger in breast cancer than in bronchial-and-lung cancer in this population, as: 855 women died from breast cancer in 2012 (2,78% of the total deaths in that year in the studied population), 892 in 2013 (2,85%) and 967 in 2014 (2,96%); and 644 women died from lung cancer in 2012 (2,09%), 619 in 2013 (1,97%) and 718 in 2014 (2,19%). In common, most deaths for both cancer occur between the ages 50 and 59, with breast cancer’s PYLL being 17.328 and bronchial-and-lung cancer’s, 9.240. The comparison of PYLL rate and unadjusted proportional mortality in the years 2012-2014 indicated that in middle west Brazil, same as nationally, female population is more affected by and loses more potential years of life for breast cancer than for bronchial-and-lung cancer.Brazil, Breast neoplasm, Lung Neoplasms, Mortality

Return